DonateDr. Mohammed Harris
Board Trustee
Mohammed Harris, PhD, MBA, MPH, MPA is a scientist–executive and nonprofit leader with deep experience at the intersection of healthcare innovation, patient advocacy, and translational research. He currently serves on multiple nonprofit Boards and the Executive Board of TimepointDx, a precision diagnostics company advancing patient-centric longitudinal multiomics technologies to improve disease monitoring and outcomes.
Dr. Harris has worked extensively with patient advocacy organizations, healthcare systems, and life-science partners to strengthen research infrastructure, elevate patient voice, and accelerate the translation of science into real-world impact. His expertise spans biomarkers, registries and natural history studies, clinical research strategy, and mission-driven organizational growth. He has previously worked in big pharma, including the likes of Johnson and Johnson, Amgen and Bristol Myers Squibb, to advance novel medicines in multiple diseases.
As a Trustee of the Diann Shaddox Foundation for Essential Tremor, Dr. Harris is committed to advancing awareness, education, and research for individuals and families affected by essential tremor. He brings a strong belief in patient-centered approaches, collaboration, and data-driven advocacy to support the Foundation’s mission and long-term impact.
Dr. Harris has worked extensively with patient advocacy organizations, healthcare systems, and life-science partners to strengthen research infrastructure, elevate patient voice, and accelerate the translation of science into real-world impact. His expertise spans biomarkers, registries and natural history studies, clinical research strategy, and mission-driven organizational growth. He has previously worked in big pharma, including the likes of Johnson and Johnson, Amgen and Bristol Myers Squibb, to advance novel medicines in multiple diseases.
As a Trustee of the Diann Shaddox Foundation for Essential Tremor, Dr. Harris is committed to advancing awareness, education, and research for individuals and families affected by essential tremor. He brings a strong belief in patient-centered approaches, collaboration, and data-driven advocacy to support the Foundation’s mission and long-term impact.
